These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3683466)

  • 1. Ethical dilemmas in the early detection of malignancy by NMR spectroscopy of plasma.
    Shaw A
    N Engl J Med; 1987 Nov; 317(21):1353. PubMed ID: 3683466
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of malignant tumors by nuclear magnetic resonance spectroscopy of plasma.
    N Engl J Med; 1987 May; 316(22):1411-5. PubMed ID: 3574419
    [No Abstract]   [Full Text] [Related]  

  • 3. Nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
    N Engl J Med; 1990 Sep; 323(10):677-81. PubMed ID: 2385273
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
    Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
    N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR--another cancer-test disappointment.
    Shulman R
    N Engl J Med; 1990 Apr; 322(14):1002-3. PubMed ID: 2314436
    [No Abstract]   [Full Text] [Related]  

  • 6. [A method of NMR-relaxometry of the blood serum applicable to the diagnosis of malignant neoplasms].
    Papish EA; Kariakina NF
    Vestn Akad Med Nauk SSSR; 1989; (7):74-81. PubMed ID: 2683466
    [No Abstract]   [Full Text] [Related]  

  • 7. Can NMR of a blood sample detect cancer or not?
    Oncology (Williston Park); 1990 Oct; 4(10):12, 15. PubMed ID: 2149822
    [No Abstract]   [Full Text] [Related]  

  • 8. [Assessment of the feasibility of using the time of NMR spin-lattice relaxation in blood serum for the diagnosis of cancer].
    Galil-Ogly GA; Dmitriev GI; Koriakina NF; Bozhenko VK; Kalachikhina OD
    Vestn Akad Med Nauk SSSR; 1987; (12):43-6. PubMed ID: 3445698
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.
    Engan T; Krane J; Klepp O; Kvinnsland S
    N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NMR research on blood plasma for tumor detection--a method for mass screening?].
    Fritzsche H; Sprinz H; Jahn H; Jorke D
    Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Fossel ET; Carr JM; McDonagh J
    N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy and tumour detection.
    Mountford CE; Tattersall MH
    Cancer Surv; 1987; 6(2):285-314. PubMed ID: 3322549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance (NMR) in neoplastic disease.
    Orr JS; Bydder GM; Pennock JM; Young IR
    J Pathol; 1983 Nov; 141(3):297-307. PubMed ID: 6319653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NMR spectroscopy of tumors].
    Itoh M; Suzuki N; Iio M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1167-72. PubMed ID: 2658814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
    Engan T
    Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Applications of 1H nuclear magnetic resonance spectroscopy and nuclear magnetic resonance-based metabonomics in tumour studies].
    Gao HC; Lin DH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):803-10. PubMed ID: 18595263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small lesions, big dilemmas: earlier detection creates ethical questions.
    Nelson B
    Cancer Cytopathol; 2011 Feb; 119(1):1-2. PubMed ID: 21319307
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental and clinical experience with NMR-tomography].
    Friedburg H; Wenz W; Fiebig H
    Rontgenpraxis; 1984 Apr; 37(4):139-45. PubMed ID: 6729609
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear magnetic resonance in the clinical laboratory.
    Bock JL
    Am J Clin Pathol; 1989 Apr; 91(4 Suppl 1):S19-26. PubMed ID: 2929512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.